Yukari Kimoto

The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling

Wataru Amano, Saeko Nakajima, Hayato Kunugi et al. · Journal of Allergy and Clinical Immunology · 2015 · 253 citations

Life Sciences, Dermatology, Molecular Biology +11

Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo

Atsuo Tanimoto, Yoshihiro Ogawa, Chika Oki et al. · Inflammation Research · 2014 · 104 citations · Full text

Medicine, Immunology, Pharmacology +17

A novel<scp>JAK</scp>inhibitor<scp>JTE</scp>‐052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents

Atsuo Tanimoto, Yuichi Shinozaki, Yasuo Yamamoto et al. · Experimental Dermatology · 2017 · 60 citations · Full text

Medicine, Dermatology, Pharmacology +17

Discovery of a Janus Kinase Inhibitor Bearing a Highly Three-Dimensional Spiro Scaffold: JTE-052 (Delgocitinib) as a New Dermatological Agent to Treat Inflammatory Skin Disorders

Satoru Noji, Yoshinori Hara, Tomoya Miura et al. · Journal of Medicinal Chemistry · 2020 · 56 citations · Full text

Medicine, Dermatology, Medicinal Chemistry +17

Does Conditioned Taste Aversion Learning in the Pond Snail<i>Lymnaea stagnalis</i>Produce Conditioned Fear?

Serina Kita, Ryuji Hashiba, Saya Ueki et al. · Biological Bulletin · 2011 · 22 citations

Life Sciences, Behavioral Sciences, Zoology +16